InsidersTradesSigma
Track the Duality Biotherapeutics, Inc. - B stock price and the full insider trade history of the company, a publicly traded company based in Hong Kong. Shares trade on HK HK, under the oversight of HKEX. Operating in the Health Care sector, Duality Biotherapeutics, Inc. - B has published 7 public disclosures. Market capitalisation: €20.2bn. The latest transaction was filed on 2 July 2026 (Purchase). Among the most active insiders: 朱忠远. All data is openly available.
Analysts rate Duality Biotherapeutics, Inc. - B Strong Buy (bullish), based on 7 analysts. Average price target: HK$434.84.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
7 of 7 declarations
Duality Biotherapeutics, Inc. is a company focused on developing biopharmaceutical therapies. It aims to create innovative treatments for serious diseases.